Innocoll Biotherapeutics

Innocoll Biotherapeutics

制药业

Princeton,New Jersey 2,955 位关注者

关于我们

Innocoll is committed to improving patient care by confronting some of today’s most important healthcare challenges. Everyone at Innocoll is united by a common goal: to deliver healthcare solutions that make a difference in patients’ lives. We take pride in fostering a culture of collaboration, and we strive to be the best possible partners to the hospitals and doctors we support. Our current late-stage product pipeline, including XARACOLL (bupivacaine HCl) implant and POSIMIR (bupivacaine solution) for infiltration use, are focused on addressing patient needs for postsurgical pain management.

网站
https://www.innocoll.com
所属行业
制药业
规模
51-200 人
总部
Princeton,New Jersey
类型
私人持股
创立
1985
领域
Pharmaceutical、Targeted Drug Delivery、Collagen-based Technologies和Medical Device

地点

  • 主要

    210 Carnegie Center

    103

    US,New Jersey,Princeton,08540

    获取路线
  • Unit 9, Block D

    Monksland Business Park, Monksland

    IE,Co. Roscommon,Athlone

    获取路线
  • Donaustra?e 24

    DE,93342 Saal/Donau

    获取路线

Innocoll Biotherapeutics员工

动态

相似主页

查看职位

融资